life sciences

New ranking puts R.I. Amgen facility at No. 3 worldwide

AMGEN’S West Greenwich facility, which makes the biologic drug Enbrel, is one of three the biopharmaceutical company has in the top 10 of Bioplan Associates’ list of the top 1,000 biologic plants in the world.
Posted 8/18/11

ROCKVILLE, Md. – A life sciences market research company published a wiki-style ranking that puts Amgen Inc.’s West Greenwich facility at No. 3 in the world.

The Top 1000 Global Biopharmaceutical Facilities Index lists the world’s biologics facilities by estimates of global and individual facility fixed capacity, manufacturing-related employment, and the number of commercial and clinical products.

BioPlan Associates Inc. said anyone can contribute data updates, but all comments and changes are subject to industry peer review.

Genentech’s Vacaville, Calif., facility earned the No. 1 spot on the ranking, with a score of 363.4 while Amgen’s Juncos, Puerto Rico, facility got No. 2, and a score of 294; its Rhode Island facility took the No. 3 spot and earned 211 points.

Rounding out the Top Five were the Lonza Group Ltd.’s Portsmouth, N.H., plant and Boehringer Ingelheim GMbH’s Biberach, Germany, facility.

Also on the list in Rhode Island were: Alexion Pharmaceuticals Inc. in Smithfield at No. 101 with a score of 33.1 and the Dow Chemical Co.’s Smithfield contract manufacturing facility at No. 501 and a score of 5.

“Where biologics are being manufactured can be more important than how much revenue is being earned from them. Manufacturing is a core operation and is a fixed, long-term commitment to a community, an employment base and a strategy,” said BioPlan about its ranking.

“The success of a biomanufacturing enterprise, or biotech cluster, depends as much on its human capital as its fixed capital, and a critical mass of educated and skilled people is needed to establish a viable cluster. Funding alone isn’t enough,” it added.

According to the website, the facilities are concentrated in: North America, 37.2 percent; Europe, 25.8 percent; Japan and “other” Asia, 9.7 percent; China, 8.5 percent; and India, 8.0 percent, and to lesser degrees in other areas.

PBN Hosted

Join PBN for the best networking event and party of the winter - January 15, 2015 - the Book of Lists Party at the Providence Public Library. Reserve your spot by December 31st and get a holiday gift from PBN!
  • Best Places to Work
    Enrollment is now open for the 7th annual Best Places to Work program. Winners w ...
  • Manufacturing Awards
    Applications are now being accepted for the 2nd Annual Manufacturing Awards. Dea ...
Purchase Data
Book of Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  • Purchase an e-File of the entire Book of Lists database
  • Purchase a printed copy of the Book of Lists
    Latest News